Stock PTGX PROTAGONIST THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Protagonist Therapeutics, Inc.

Equities

PTGX

US74366E1029

Market Closed - Nasdaq
Other stock markets
 21:00:00 01/05/2024 BST 		5-day change 1st Jan Change
25.56 USD +1.79% Intraday chart for Protagonist Therapeutics, Inc. -0.54% +11.47%
04-03 Protagonist Therapeutics Insider Sold Shares Worth $707,750, According to a Recent SEC Filing MT
03-26 Protagonist Therapeutics, Inc. Provides Update on Verify Patient Enrollment and Timing of Top-Line Data CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
PROTAGONIST THERAPEUTICS, INC.
Other Biotechnology & Medical Research
+1.79%-0.54%+11.47%+8.54%+153.57% 1.47B
Bearish
Bullish
Bullish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. PTGX Stock
  4. Charts Protagonist Therapeutics, Inc.
  5. Comparison Chart